CardioComm Solutions Announces Issuance of Stock Options and Shares
11 Abril 2014 - 3:59PM
Access Wire
TORONTO, ONTARIO / ACCESSWIRE / April 11, 2014
/ CardioComm Solutions, Inc. (TSX VENTURE:EKG)
("CardioComm Solutions" or the "Company") today announced that it
has granted an aggregate of 500,060 incentive stock options.
250,060 options have been granted to Mr. Etienne Grima, the
Company's Chief Executive Officer, and 250,000 options have been
granted to a contractor of the Company. The 500,060 options issued
are exercisable at $0.144 per share for five years from the date of
grant, vest equally over 18 months at the end of each three month
period from the date of grant and are subject to a four month hold
period. The grant of options is subject to the provisions of the
Company's Omnibus Share Compensation Plan, the policies of the TSX
Venture Exchange and applicable securities laws.
The Company also announced that it intends to issue an aggregate
of 79,693 common shares of the Company to Simi Grosman, a director
of the Company. The shares will be issued at a deemed price of
$0.10 per share, for a total value of $8,000, for services rendered
to the Company in the months of January, February and March of 2014
pursuant to a services agreement previously disclosed by the
Company on March 8, 2013. The shares will be issued at a 5% premium
to the closing price of the Company's shares at the end of each
month in which services were provided. The issuance of shares is
subject to approval by the TSX Venture Exchange.
About CardioComm Solutions
CardioComm Solutions' patented and proprietary technology is
used in products for recording, viewing, analyzing and storing
electrocardiograms (ECGs) for diagnosis and management of cardiac
patients. Products are sold worldwide through a combination of an
external distribution network and a North American-based sales
team. The Company has earned the ISO 13485 certification, is HPB
approved, HIPAA compliant, and has received FDA market clearance
for its software devices. CardioComm Solutions is headquartered in
Toronto, Ontario, Canada, with offices in Victoria, B.C.
FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425 x 227
investorrelations@cardiocommsolutions.com
http://www.cardiocommsolutions.com/
Forward-looking statements
This release may contain certain forward-looking statements and
forward looking information with respect to the financial
condition, results of operations and business of CardioComm
Solutions and certain of the plans and objectives of CardioComm
Solutions with respect to these items. Such statements and
information reflect management's current beliefs and are based on
information currently available to management. By their nature,
forward-looking statements and forward-looking information involve
risk and uncertainty because they relate to events and depend on
circumstances that will occur in the future and there are many
factors that could cause actual results and developments to differ
materially from those expressed or implied by these forward-looking
statements and forward-looking information.
In evaluating these statements, readers should: specifically
consider risks discussed under the heading "Risk Factors" in the
Company's Annual Information Form, available at
http://www.sedar.com/; not to place undue reliance on
forward-looking statements and forward-looking information; be
aware the Company does not assume any obligation to update the
forward-looking statements and forward-looking information
contained in this Annual Information Form other than as required by
applicable laws, including without limitation Section 5.8(2) of
National Instrument 51-102 (Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
CardioComm Solutions (TSXV:EKG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
CardioComm Solutions (TSXV:EKG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024